Factor VIII (FVIII)
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors (NCT03734588) | Spark Therapeutics, Inc. | 2019-01-30 |
Track Factor VIII (FVIII) automatically
Every clearance here is in the API, with alerts when new ones post.